Matinas Biopharma (MTNB) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Matinas Biopharma is the larger company by market cap ($2.8 million vs $1.5 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MTNB | SBFM |
|---|---|---|
| Share price | $2.87 | $0.3378 |
| Market cap | $2.81M | $1.46M |
| 1-day change | +1.41% | -21.44% |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $-17.55 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $24.30 |
| 52-week low | $2.27 | $0.3312 |
| Distance from 52-week high | -90.09% | -98.61% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +16477.86% |
| Average volume | 412.79K | 5.34M |
| Shares outstanding | 979.52K | 4.31M |
| Employees | 2 | 50 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Sunshine Biopharma
SBFM stock →Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 50 employees
MTNB vs SBFM FAQ
Which is bigger, Matinas Biopharma or Sunshine Biopharma?
Matinas Biopharma (MTNB) is larger, with a market capitalization of $2.81M compared with $1.46M for Sunshine Biopharma (SBFM).
Are Matinas Biopharma and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.